Official Title: “Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics”

The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence.

Study Type: Interventional

Study Design: Treatment, Randomized

Study Primary Completion Date: February 2003

The purpose of the proposed research is to implement and systematically evaluate, in community treatment settings, motivational incentive procedures that have been well researched and have proven efficacious in a variety of treatment research clinics.

Intervention(s) in this Clinical Trial

• Behavioral: Behavior Therapy

Primary Measures

• ASI
• Cocaine use
• AIDS risk behavior

Inclusion Criterea:

• New intake to a drug-free CTP
• Evidence of cocaine or methamphetamine use, any reported use in past 2 weeks or positive urine screen at study intake. For those exiting a controlled environment, any stimulant use within two weeks of entering the controlled environment

Exclusion Criteria:

• Unable to give informed consent (fails simple consent quiz)
• Answers yes to question: Are you in recovery from gambling? That is, have you stopped gambling because of previous problems with gambling?

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: N/A

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Overall Clinical Trial Officials and Contacts

Maxine Stitzer, Ph.D. Principal Investigator Johns Hopkins University  

Information obtained from ClinicalTrials.gov on January 06, 2009

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00033007

Study ID Number: NIDA-CTN-0006-1

ClinicalTrials.gov Identifier: NCT00033007

Health Authority: United States: Federal Government

Data Elements